Ranbaxy gets FDA nod to sell generic Diovan tablets in US

Drug major Ranbaxy Laboratories has received US health regulator's approval to market generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the US......

Ranbaxy returns to profit in Q2 on robust volumes

Drug firm Ranbaxy Laboratories on Monday reported a consolidated net profit of Rs 477.75 crore (Rs 4.77 billion)for the quarter ended September 30, 2014 on account of robust sales. The company had......

Ranbaxy shares jump on drug approval in US

Shares of Ranbaxy Laboratories rose more than 5 per cent after the company announced a US regulatory approval for a hypertension drug to be launched by one of its subsidiaries. The stock rose by......

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

After its Paonta Sahib and Dewas units, Ranbaxy’s third and newly commissioned Mohali facility, too, appears to have come under the US regulator’s scanner. After finding deviations from......